Systemic sclerosis & Raynaud's

Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

Rheumatology (Oxford)Published Mechanistic study

Authors' conclusion

Despite not fulfilling classification criteria, VEDOSS patients show SSc-linked fibrosis and immunity dysregulation both within the tissue and sera, supporting a biological diagnosis of disease and a window of opportunity to detect the biological pathways amenable for preventive intervention.

Study context

Population
Patients with Very Early Diagnosis of SSc (VEDOSS) in the EUSTAR study36 with skin biopsies
Participants
114 patients
Comparison
VEDOSS vs healthy controls
  • VEDOSSn = 114
Outcome
Biological SSc activity in VEDOSS skin, fibroblasts and serum
Methodological detailsconsecutive patients, longitudinal follow-up
  • Consecutive patients
  • Longitudinal follow-up

Main finding

As reported in the abstract

  • Skin biopsies: variable but overall increased collagen staining and skin thickness, increased perivascular infiltrate of CD45-positive cells and CXCL10 expression
  • VEDOSS dermal fibroblasts: increased profibrotic gene expression and contractibility vs healthy controls (HC)

Further findings

OutcomeVEDOSSHCP value
Serum CXCL10VEDOSS vs HC · mean, pg/ml75.90 (SD 107.80)39.90 (SD 26.27)P = 0.02
ELF scoreVEDOSS vs HC · reported as increased in VEDOSS vs HC8.19 (SD 0.78)8.55 (SD 0.79)P = 0.04
Progression to SSc (longitudinal) · median 27.5 (IQR 44.5) months14.9%— not stated in the abstract

— not stated in the abstract

Progression to SSc (longitudinal) — Baseline serum CXCL10 higher in VEDOSS patients who progressed (2-fold increase)
P = 0.0071
Progression to SSc (longitudinal) — Baseline CXCL10 correlated with ELF score (R = 0.3096)
P = 0.0065

Original publication

Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Rheumatology (Oxford). Published 19 December 2024. doi:10.1093/rheumatology/keae698

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.